Search results
Bristol-Myers Squibb Snags Another Approval for This Mega-Blockbuster Drug
Motley Fool· 2 years agoLast month, Bristol-Myers Squibb's (NYSE: BMY) third-best-selling drug, Opdivo, in conjunction with...
Could This Indication Provide a Lift for Bristol Myers Squibb's Stock?
Motley Fool· 1 year agoLate last month, Bristol Myers Squibb's (NYSE: BMY) immunology drug, Sotyktu, received good news....
Bristol Myers sales fall, cuts 2023 forecast as drugs face competition
Reuters via AOL· 9 months ago(Reuters) -Bristol Myers Squibb on Thursday said its second-quarter sales fell more than expected...
A Beacon of Hope
ACCESSWIRE via Yahoo Finance· 1 year agoBristol Myers Squibb has a long-standing partnership with The Leukemia & Lymphoma Society (LLS) and has been the top biopharma fundraising team for Light...
What's in Store for Bristol-Myers (BMY) in Q3 Earnings?
Zacks via Yahoo Finance· 6 months agoBristol-Myers Squibb Company BMY is scheduled to report third-quarter 2023 results on Oct 26, before...
What You Need to Know Ahead of Bristol-Myers (BMY) Q4 Earnings
Zacks via Yahoo Finance· 3 months agoBristol-Myers Squibb Company BMY is scheduled to report fourth-quarter 2023 results on Feb 2, before...
Bristol Myers Squibb (BMY) Q2 2023 Earnings Call Transcript
Motley Fool· 9 months agoAt this time, I'd like to turn the floor over to Tim Power, vice president of investor relations....
Is This Monster Stock On Its Way to Another Multibillion-Dollar Drug?
Motley Fool· 2 years agoA promising cancer drug combo from Bristol Myers Squibb is months away from being approved in the...
Bristol Myers accused of illegal tactics to keep Pomalyst monopoly in lawsuit
Reuters via AOL· 8 months agoBristol Myers Squibb has been accused in a new lawsuit of using fraudulent patents and other illegal...
Bristol-Myers (BMY) Q2 Earnings, Sales Miss, '23 View Lowered
Zacks via Yahoo Finance· 9 months agoBristol-Myers' (BMY) second-quarter 2023 earnings and sales miss estimates due to generic erosion...
